Outbreak Caused by blaOXA-72-Producing Acinetobacter baumannii ST417 Detected in Clinical and Environmental Isolates
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
We characterized an outbreak of imipenem-resistant Acinetobacter baumannii with clinical and environmental isolates from a tertiary care hospital in San Luis Potosi, Mexico. During a 4-month period, a total of 32 nonrepetitive imipenem-resistant clinical isolates of A. baumannii were collected. All isolates were susceptible to colistin and tigecycline and resistant to cefepime, ceftazidime, ceftriaxone, imipenem, and meropenem. Genotyping by pulsed-field gel electrophoresis showed a major clone (A). Multilocus sequence type (MLST) analysis was performed, revealing sequence type (ST) 417 (ST417) and 208 (ST208). The blaIMP-, blaVIM-, blaGIM-, blaSIM-, blaNDM-type, and blaOXA-type (blaOXA-23-like, blaOXA-24-like, blaOXA-51-like, and blaOXA-58-like) genes were screened and showed that the blaOXA-51-like and blaOXA-24-like genes were present in all isolates. Sequencing and southern hybridization were performed, confirming the presence of the blaOXA-72 gene and its plasmid-borne nature. In addition, the blaOXA-72-XerC/XerD-like association was identified. These findings indicate that a clonal spread of blaOXA-72-producing A. baumannii ST417 had occurred throughout the hospital. The ST417 corresponded with a previous ST described in the United States. © Copyright 2016, Mary Ann Liebert, Inc. 2016.
publication date
published in
Research
keywords
-
amikacin; bacterial protein; bla ox 72 protein; cefepime; ceftazidime; ceftriaxone; ciprofloxacin; colistin; gentamicin; imipenem; levofloxacin; meropenem; piperacillin plus tazobactam; tigecycline; timentin; unclassified drug; antiinfective agent; bacterial DNA; beta lactam; beta lactamase; colistin; isoenzyme; minocycline; Acinetobacter baumannii; antibiotic resistance; antibiotic sensitivity; Article; bacterium isolate; clone; epidemic; gene insertion sequence; gene sequence; genotype; multilocus sequence typing; nonhuman; plasmid; priority journal; pulsed field gel electrophoresis; Southern blotting; Acinetobacter baumannii; Acinetobacter Infections; analogs and derivatives; chemistry; DNA sequence; drug effects; enzymology; epidemic; gene expression; genetics; human; isolation and purification; metabolism; Mexico; microbial sensitivity test; microbiology; multidrug resistance; tertiary care center; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Colistin; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Humans; Isoenzymes; Mexico; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA; Tertiary Care Centers
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue